We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Final packaging is often the last process step before a product leaves a factory. Any failure in the process at this point puts the cost of the finished and filled drug at risk, as well as the capacity of the process.
Vision inspection of final packaging components offers a way to improve yields and increase capacity. Upgrading to these components can help to reduce end-of-line variability and improve processes.To determine if adding vision inspection to packaging components is the right thing for your drug product, ask yourself three simple questions:
If you answered yes to these questions, then moving to vision-inspected packaging components may be a good choice. Reducing variability can improve quality and yield, can reduce product cost and time spent investigating non-conforming batches. Selecting vision-inspected components also can increase capacity.
West is a pioneer in vision inspection technology. The Envision™ automated inspection system can enhance the quality of Westar® ready-to-sterilize components by significantly reducing adhered and embedded particulate, helping to improve consistency.
Many of our standard products are available in Envision-verified formats – an upgrade that can be made simply by talking to your sales representative as there’s no need for a complex development agreement or regulatory change burden. Many of West’s current items are available with Envision verification, enabling you to benefit from the advantages of a tighter specification and reduced end-of-line component failure risks while preserving all the features of your current formulation, configuration, finishing, packaging and other key details. This approach to upgrade, which leaves the fundamentals of your component’s production and preparation unchanged, is not associated with any additional testing or regulatory change burden.
Contact us to speak with a Technical Customer Service representative to see if your products are pre-qualified as Envision automated inspection system.
Spotting a quality issue on a stopper or plunger can be difficult. While a trimming or molding defect may be noticeable, embedded particulate or foreign contamination may be far too small for the human eye to see. <br />
In today’s manufacturing processes, defects such as loose and embedded foreign matter may cause end of line rejects of drug products—potentially leading to a loss of product or even market recalls. At the same time, regulatory authorities are becoming increasingly more stringent and continually lowering acceptable levels of particulate matter.
<p><span>The overall quality of a final drug product depends on the components of its packaging and delivery systems. The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.</span></p>
<strong>NovaPure® Components Overview</strong><br /><em>By leveraging nearly 100 years of pharmaceutical packaging knowledge and implementing Quality by Design principles, West has developed the continuously improving NovaPure® elastomer portfolio which can be ideal for all drug product phases.</em>
Few topics generate as much interest as the reduction of drug manufacturing end-of-line rejects, which is one of the clearest and easiest ways to reduce waste and maximize operating profit and may help improve patient safety. One of the largest contributing factors to the end-of-line reject rate is the quality of the packaging components selected for the drug product.
English
Chinese
